Revolution Medicines, Inc. (NASDAQ:RVMD) Q1 2023 Earnings Call Transcript May 8, 2023
Revolution Medicines, Inc. beats earnings expectations. Reported EPS is $-0.72, expectations were $-0.81.
Operator: Good day and welcome to Revolution Medicine’s First Quarter 2023 Earnings Conference Call. As a reminder, today’s conference is being recorded. I would now like to turn the conference over to your host, Erin Graves, Senior Director of Corporate Communications and Investor Relations. Erin,...
